-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
11 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$36.37 M
Apellis Pharmaceuticals, Inc. Insider Transactions
Apellis Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Sell | 2,000 @ $63.95 | $127,900 | 93,338 | 03/01/2024 | 03/05/2024 | ||
|
Watson David O.
General Counsel |
Sell | 781 @ $67.77 | $52,926 | 103,390 | 02/12/2024 | 02/13/2024 | |
|
Townsend Adam J.
Chief Commercial Officer |
Sell | 1,148 @ $67.77 | $77,796 | 92,453 | 02/12/2024 | 02/13/2024 | |
| Sell | 1,431 @ $67.77 | $96,974 | 93,338 | 02/12/2024 | 02/13/2024 | ||
|
Francois Cedric
CEO |
Sell | 3,962 @ $67.77 | $268,492 | 313,662 | 02/12/2024 | 02/13/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 1,148 @ $67.77 | $77,796 | 1,115,983 | 02/12/2024 | 02/13/2024 | |
|
DeLong Mark Jeffrey
Chief Business & Strat Officer |
Sell | 597 @ $67.77 | $40,457 | 64,606 | 02/12/2024 | 02/13/2024 | |
|
Lewis Karen
Chief People Officer |
Sell | 883 @ $65.53 | $57,863 | 46,387 | 01/30/2024 | 01/31/2024 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 971 @ $65.53 | $63,630 | 57,208 | 01/30/2024 | 01/31/2024 | |
|
Watson David O.
General Counsel |
Sell | 906 @ $64.14 | $58,109 | 104,171 | 01/29/2024 | 01/31/2024 | |
|
Townsend Adam J.
Chief Commercial Officer |
Sell | 906 @ $64.14 | $58,109 | 93,601 | 01/29/2024 | 01/31/2024 | |
| Sell | 906 @ $64.14 | $58,109 | 94,769 | 01/29/2024 | 01/31/2024 | ||
|
Nicholson Nur
Chief Technical Officer |
Sell | 835 @ $64.14 | $53,555 | 67,507 | 01/29/2024 | 01/31/2024 | |
|
Lewis Karen
Chief People Officer |
Sell | 367 @ $64.14 | $23,539 | 47,270 | 01/29/2024 | 01/31/2024 | |
|
Francois Cedric
CEO |
Sell | 2,843 @ $64.14 | $182,345 | 317,624 | 01/29/2024 | 01/31/2024 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 279 @ $64.14 | $17,895 | 58,179 | 01/29/2024 | 01/31/2024 | |
|
Deschatelets Pascal
Chief Scientific Officer |
Sell | 874 @ $64.14 | $56,057 | 1,117,131 | 01/29/2024 | 01/31/2024 | |
|
DeLong Mark Jeffrey
Chief Business & Strat Officer |
Sell | 367 @ $64.14 | $23,539 | 65,203 | 01/29/2024 | 01/31/2024 | |
|
Lewis Karen
Chief People Officer |
Sell | 4,286 @ $63.69 | $272,975 | 47,637 | 01/23/2024 | 01/24/2024 | |
|
Eisele Jeffrey
Chief Development Officer |
Sell | 7,378 @ $63.69 | $469,905 | 58,458 | 01/23/2024 | 01/24/2024 |
Apellis Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Apellis Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Apellis Pharmaceuticals, Inc. includes Sullivan Timothy Eugene, Townsend Adam J., Watson David O., Nicholson Nur, DeLong Mark Jeffrey, Lewis Karen, Chopas James George, Deschatelets Pascal, Eisele Jeffrey, Francois Cedric, Dunlop A. Sinclair.
-
How much insider selling is happening at Apellis Pharmaceuticals, Inc.?
Insiders have sold a total of 609,671 Apellis Pharmaceuticals, Inc. shares in the last 12 months for a total of 36.37 M sold.
-
Which Apellis Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Apellis Pharmaceuticals, Inc. shares in the last 12 months: Sullivan Timothy Eugene ($1.15 M), Townsend Adam J. ($507,054), Watson David O. ($666,247), Nicholson Nur ($991,991), DeLong Mark Jeffrey ($826,965), Lewis Karen ($791,212), Chopas James George ($137,072), Deschatelets Pascal ($11.88 M), Eisele Jeffrey ($997,353), Francois Cedric ($17.35 M), Dunlop A. Sinclair ($1.07 M),